Champix
Pfizer says EMA lifts warning on its smoking cessation drug Champix
May 24, 2016Manufacturing and Production, Research and Development, Sales and Marketing Champix, EMA, Pfizer, anti-smoking, drug trial
US pharma giant Pfizer (NYSE: PFE) said the European Medicines Agency has lifted a warning on its anti-smoking drug Champix …
FDA gives new safety warning on Pfizer’s Champix
March 10, 2015Manufacturing and Production, Sales and Marketing Champix, Cochrane, FDA, MHRA, Pfizer, varenicline
The FDA has warned that Pfizer’s stop smoking drug Champix is linked with seizures, aggressive behaviour and blackouts. In its …
Smoke and fire in J&J Code breach
August 15, 2012Sales and Marketing Champix, J&J, JJ, Johnson and Johnson, PMCPA, Pfizer
Johnson & Johnson has been censured for breaking the ABPI Code of Practice in printed information about its smoking cessation …
Champix better than patches for smoking cessation
August 7, 2012Sales and Marketing Champix, FDA, Pfizer, Zyban, smoking
New research shows that Pfizer’s Champix is better than nicotine patch therapy at helping smokers kick the habit. A Pfizer …
Forecasting future launch success
September 8, 2011Sales and Marketing Champix, Enbrel, forecast planning, forecasting
Pharmaceutical companies are moving into new and sometimes very different (often specialised) therapy areas, because of global market conditions and …
Study claims cardiovascular risk to Pfizer’s Champix
July 6, 2011Research and Development, Sales and Marketing Champix, Chantix, Pfizer, smoking cessation
Pfizer has been drawn into a war of words over its smoking cessation drug Champix after a review of existing …
Boost for Pfizer’s Champix from NHS quit smoking report
August 22, 2008Sales and Marketing Champix, smoking
Pfizer's smoking cessation drug Champix is the most effective pharmaceutical aid to quitting, according to new figures. A report on …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
